HAI2024 Book - Flipbook - Page 2
TABLE OF CONTENTS
TABLE OF CONTENTS ....................................... 2
SUPPORTERS ................................................... 15
1 Longitudinal synaptic loss follows
tau PET Braak staging in vivo and
supports local neurodegeneration by
tau accumulation in stages III-VI....92
HAI COMMITTEES ............................................. 16
Jang, Hyemin .............................................. 95
WELCOME! ....................................................... 14
POSTER INDEX (by presenter’s last name) ..... 17
POSTER INDEX (by board number) ................. 29
HAI 2024 PROGRAM ......................................... 41
HAI 2024 ABSTRACTS .................................... 64
Wednesday, January 17, 2024 08:30 am - 09:35 am ..................... 64
Podium Session............................. 64
SESSION I: Tracer Discovery and Biomarker
Optimization .................................................. 64
2 Plasma Aβ42/40 ratio, GFAP, and
NfL across the neurodegenerative
diseases: cross-sectional and
longitudinal study in a large multicenter cohort .................................95
Schwarz, Christopher .................................. 96
3 Publicly available software and
FTP calibration data for CenTauR tau
PET standardization .......................96
Lee, Eun Hye................................................ 99
Discovery and preclinical
development of [18F]ACI-19626, a
first-in-class TDP-43 PET tracer ...65
4 The impact of metabolic health
on the relationship of obesity with
and Alzheimer’s and vascular
markers .......................................... 99
Honhar, Praveen .......................................... 66
Kang, Sung Hoon ....................................... 100
Bridging the gap between SUVR and
DVR for [18F]MK6240 by correcting
for tracer clearance in tissue: A
simulation study.............................66
5 Distinct effects of cholesterol
profile components on Amyloid and
Vascular burdens ......................... 100
Vokali, Efthymia .......................................... 65
Farrell, Michelle ........................................... 70
Chun, Min Young ......................................... 101
PET Spatial extent as a sensitive
beta-amyloid biomarker in
preclinical Alzheimer’s disease .....70
6 Amyloid pet positivity in Korean
Dementia Syndromes: in relation to
diagnosis, age, and Apoe genotypes
....................................................... 101
Villeneuve, Sylvia ......................................... 72
Shaaban, C. Elizabeth ................................ 102
Optimizing the detection of wholebrain tau-related cognitive decline in
mild cognitive impairment ............. 72
7 Toward more representative
estimates of the effect of tau on
cognition ...................................... 102
Zanotti-Fregonara, Paolo ............................ 75
DiFilippo, Alexandra ................................... 104
Keynote: Targets and radioligands
for PET imaging of
neuroinflammation ........................ 75
8 Examination of synaptic density
and neurofibrillary tau tangle burden
in cognitively unimpaired and
impaired older adults ................... 104
Wednesday, January 17, 2024 - 10:25
am - 10:55 am ................................. 76
Break/Poster Session .................................... 76
Vanderlinden, Greet .....................................92
Fernandez, Jaime ...................................... 106
9 Association between plasma Ptau and cognition in the Alzheimer's
disease spectrum ........................ 106